Leica Microsystems Advances AI-Powered Analysis for Multi-well Assays with Aivia 16
July 6, 2026
Software enhancements help researchers simplify complex studies and generate results with confidence Wetzlar, Germany – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific solutions, announced today the release of Aivia 16, the newest version of its AI-powered image analysis software, helping researchers analyze complex multi-well assay data faster and with [...]
Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer
July 6, 2026
Former Bionano Genomics Chief Medical Officer joins Nabsys at a pivotal moment as the Company expands commercialization of its electronic genome mapping platform Dr. Chaubey will lead medical and scientific affairs strategy as Nabsys works to expand global access to high-resolution structural variant analysis for cancer, constitutional, and cell and gene therapy applications PROVIDENCE, R.I. -- Nabsys [...]
July 6, 2026
Cambridge, UK – bit.bio, the Cambridge-based human cell programming company, has today announced the launch of two new cell culture media kits designed to make human cell-based research significantly more accessible and affordable for laboratories worldwide. Developed for use with bit.bio's human iPSC-derived ioGlutamatergic Neurons and ioMicroglia, the easy-to-use media kits remove one of the major [...]
July 6, 2026
LOVELAND, Colo. -- Today, Hach unveils the DR4900 Spectrophotometer to meet laboratories' demand for accurate, efficient, and user-friendly water analysis. Built on Hach's legacy of trusted spectrophotometry technology since 1955, the DR4900 is a next-generation instrument engineered to empower lab professionals in municipal and industrial facilities to achieve precise results. Meet the New DR4900 Spectrophotometer [...]
July 6, 2026
Agreement expands Active Motif's research genomics portfolio while supporting Arima's strategic focus on its clinical diagnostics platform CARLSBAD, Calif. -- Active Motif, a leading provider of epigenetics and multiomic solutions to mechanistic, translational, and clinical researchers, today announced an exclusive global commercial distribution agreement with Arima Genomics, a cancer diagnostics company built on leadership in [...]
July 6, 2026
Recently, ACROBiosystems has officially received the "Material Suitability Confirmation for Regenerative Medicine Products" (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan for its GMP-grade Human IL-15 protein. This recognition further validates ACROBiosystems' quality system and serves as an authoritative endorsement of its compliance capabilities and expertise in the core raw [...]
July 3, 2026
Shimadzu Corporation has begun a pilot program with Ryukoku University to pilot trial a refurbishment business for used analytical and measuring instruments (products that have been repaired and serviced by the manufacturer). This initiative is being implemented as part of the “Comprehensive Partnership Agreement for the Creation of a Circular Society” signed by both Parties [...]
July 3, 2026
SHENZHEN, China — MGI’s subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, today announced the launch of two breakthrough innovations that close the gap between digital intelligence and physical execution in biology: ProtoPilot, a self-evolving multi-agent system driven by real-world laboratory scenarios; and BioLab Bench, the industry’s first comprehensive evaluation framework that assesses [...]
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
July 2, 2026
No Stockholder Action Required at This Time REDWOOD CITY, Calif. -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class [...]
AnalytiChem continues global product brand transition for Bernd Kraft, Chem-Lab, and SCP Science
July 2, 2026
AnalytiChem consolidates chemicals product expertise, innovation and heritage under one unified global brand AnalytiChem brings together Bernd Kraft, Chem-Lab and SCP Science under a unified global AnalytiChem product brand Eschborn, Germany -- AnalytiChem, manufacturer of specialized chemicals, reagents, accredited standard, equipment and consumables, has announced that the brand transition of its chemical product ranges, currently [...]

